The Director, Directorate of Medical Education & The Chairperson, Board of Diploma in Pharmacy Examinations v. Fathima College of Pharmacy, The Pharmacy Council of India & The LBS Centre for Science & Technology
Case Details & Bench
- Court
- High Court of Kerala
- Hon'ble Judges
- Antony Dominic
- Dama Seshadri Naidu
- Judgment Date
- 2017-12-18
- Court Decision / Holding
- WA No.1706/2017 is dismissed. WA No.319/2017 is disposed of, confirming the learned Single Judge’s judgment and directing the management to remit Rs. 3,00,000 to the Government within one month.
- Final Disposition
- W.A.1706/2017 dismissed; W.A.319/2017 disposed of with confirmation of the Single Judge’s judgment and a monetary penalty directed against the management, payable to the Government within one month.
Parties to the Case
Appellants / Petitioners
- The Director, Directorate of Medical Education
- The Chairperson, Board of Diploma in Pharmacy Examinations
Respondents
- Fathima College of Pharmacy, Kollam
- The Pharmacy Council of India
- The LBS Centre for Science & Technology
Legal Representation & Advocates
Counsels for Petitioners
- • Government Pleader Sri. Aravinda K. Babu
Counsels for Respondents
- • Adv. Suvin R. Menon (CGC)
- • Adv. P.B. Krishnan
- • Adv. Sabu George
- • Adv. P.M. Neelakandan
- • Adv. P.B. Subramanyan
- • Adv. S. Nithin (Anchal)
- • N. Nagareesh, Assistant Solicitor General
Case Synopsis & Summary
These writ appeals challenge a common Kerala High Court judgment disposing WP(C) Nos. 24031/2016 and 36292/2016, both filed by Fathima College of Pharmacy. The central dispute concerns excess admission in the 2015-16 academic year and regulatory action under the Pharmacy Act, 1948. The learned single Judge held that the State had no power under Section 13 to withdraw recognition and that the remedy lay with the Pharmacy Council of India (PCI), citing Jaya Gokul Educational Trust v. Commissioner and Secretary to Government and St. Joseph’s Hospital Trust v. Kerala University of Health Sciences to support the PCI-centric approach for withdrawal of recognition. On appeal, the Division Bench dismissed WA No.1706/2017 (the State’s challenge to the withdrawal/recognition issue) and upheld the judgment in WA No.319/2017, which concerned admissions for 2015-16. The Bench emphasized that the total seats permissible by the Pharmacy Council is 120, with a 50:50 split between merit quota and management quota. It directed the management to reduce the excess six admissions in the subsequent year and imposed a financial penalty of Rs.50,000 per student (total Rs.3,00,000) payable to the Government to deter future irregularities, payable within one month. The combined outcome clarifies regulatory authority and the consequences of excess admissions.
Provisions of Law Cited
Submissions & Arguments
Contentions of Appellants / Petitioners
The State contends that under Section 13 of the Pharmacy Act, 1948, withdrawal of recognition is not available to the State; the appropriate course is to notify PCI and have them withdraw recognition, with PCI alone empowered to take such action. It argues that the excess admissions in 2015-16 were a matter to be addressed through regulatory channels (reduction of seats, reporting to PCI) rather than unilateral state action to withdraw recognition, and that penal measures are proportionate to deter future irregularities rather than penalizing students. It emphasizes that the LBS Centre’s allotments and the 50:50 merit-management split require adherence to regulatory feasibility, and that regularisation, if any, should occur only through PCI.
Contentions of Respondents
Fathima College of Pharmacy and allied bodies argued that the admissions were regularized by PCI and that the college acted within the 50:50 framework agreed with LBS Centre; they contend that the State’s attempt to penalize management by reducing seats not only disrupts academic years but exceeds regulatory bounds, and that PCI’s prior recognitions were appropriately granted. They emphasize that any withdrawal power rests with PCI and that the State should cooperate with PCI rather than usurp its authority; they highlight that the irregular admission was not a deliberate fraud but a regulatory anomaly that PCI had previously recognized or acknowledged.
Cited Precedents (2)
| Case Name | Citation | Treatment | Explanation |
|---|---|---|---|
| Jaya Gokul Educational Trust v. Commissioner and Secretary to Government | 2000 (2) KLT 267 (SC) | Positive | Cited by the learned Judge to support that withdrawal of recognition is the domain of the Pharmacy Council of India, not the State government. |
| St. Joseph's Hospital Trust v. Kerala University of Health Sciences | 2012 (4) KLT 444 | Positive | Cited to reinforce the principle that the State should refer issues of withdrawal or regulatory action to PCI, with withdrawal being PCI’s prerogative. |
Diagnostic Tool
Does this judgment govern your specific facts?
Don't risk relying on a distinguishable precedent. Enter your facts or proposition below. We will test it against The Director, Directorate of Medical Education & The Chairperson, Board of Diploma in Pharmacy Examinations v. Fathima College of Pharmacy, The Pharmacy Council of India & The LBS Centre for Science & Technology and instantly map out authorities that support, challenge, or govern your position.
Extracted Judgment Text
Exact text extracted from official judgment records.